ViroGates A/S

VIRO · Nasdaq Copenhagen · Healthcare

9.30DKK +16.3%last day

Price as of 2 October 2026

The price over the past year, with dividends: −4.7%

Performance

1 month

−16.2%

1 year

−4.7%

3 years, per year

−16.3%

5 years, per year

−40.8%

Largest fall, 3 years

−97.0%

Below the peak now

−94.9%

Volatility, 1 year

94.0%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

5.3

Dividend yield

0.0%

Return on equity

−46.7%

Net margin

−88.6%

Market value

13 m USD

Quality, value and trend

Where ViroGates stands against every Nordic stock today. 100 is best.

Quality71

Profitability and a sound balance sheet over time. Better than 71% of Nordic stocks.

Value6

The price measured against earnings, assets and cash flow. Better than 6% of Nordic stocks.

Trend33

The price development over the past year. Better than 33% of Nordic stocks.

Combined23

Quality, value and trend together. Better than 23% of Nordic stocks.

About ViroGates

ViroGates A/S is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 7 employees.

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis